Clinical trials: Elders
Elder
Pharmacokinetics of Leritrelvir(Ray1216) in Elder Participants
The purpose of this study is to assess the safety, tolerability and PK of Leritrelvir in elder participants
- Trial name
- NCT06169085
- Testing
- Leritrelvir
- Where
- China
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
Elder
Pharmacokinetics of ZSP1273 in Elder Participants
The purpose of this study is to assess the safety, tolerability and PK of ZSP1273 in elder Participants
- Trial name
- NCT06157450
- Testing
- ZSP1273
- Where
- China
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
Elder
Safety and Pharmacokinetics of SIM0417 Combined With Ritonavir in Healthy Elderly Subjects
This is a non-randomized, open-label, single-dose, Phase I clinical study and plans to enroll 12-20 healthy elderly subjects aged 65 and above, including 3-6 subjects aged 75 and above, both men and women.
- Trial name
- NCT05826249
- Testing
- SIM0417/Ritonavir
- Where
- China
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
Healthy Elder People
Feasibility Clinical Study of NLA Tool
The study is to evaluate the feasibility of the NLA tool, a combined assessment of nutritional and physical functional status, to provide personalized advice for the independence and mobility of elderly.
- Trial name
- NCT01985282
- Testing
- Nutrition Status Questionnaires and Physicial Function Test
- Where
- Japan
- Volunteers
- 250 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)